Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CEO Sells 85,788 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 85,788 shares of Tempus AI stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $53.39, for a total value of $4,580,221.32. Following the transaction, the chief executive officer now owns 5,771,787 shares of the company’s stock, valued at $308,155,707.93. The trade was a 1.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Tempus AI Price Performance

TEM stock opened at $51.40 on Friday. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49. The business’s 50-day moving average is $44.36 and its 200 day moving average is $47.68. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Institutional Trading of Tempus AI

Institutional investors have recently made changes to their positions in the company. Novo Holdings A S purchased a new position in Tempus AI in the 2nd quarter valued at $142,605,000. ARK Investment Management LLC raised its position in shares of Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after buying an additional 1,855,459 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after buying an additional 1,145,698 shares in the last quarter. NEA Management Company LLC boosted its position in Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after acquiring an additional 813,169 shares during the last quarter. Finally, Perceptive Advisors LLC acquired a new position in shares of Tempus AI during the 2nd quarter valued at about $9,625,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

TEM has been the subject of several recent research reports. Bank of America lifted their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 target price on shares of Tempus AI in a report on Tuesday, January 14th. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. Wolfe Research assumed coverage on shares of Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective for the company. Finally, Loop Capital lowered their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Tempus AI has a consensus rating of “Moderate Buy” and an average price target of $56.36.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.